| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 05/16/2006 | US7045639 Method for purifying N-(2-hydroxyethyl)-2-pyrrolidone |
| 05/16/2006 | US7045636 MCH antagonists for the treatment of obesity |
| 05/16/2006 | US7045499 Therapeutic agent |
| 05/16/2006 | CA2527069A1 Polyaspartimides |
| 05/16/2006 | CA2244903C Hydroxamic acid derivatives for use with the treatment of diseases related to connective tissue degradation |
| 05/16/2006 | CA2237752C Novel substituted aryl compounds useful as modulators of acetylcholine receptors |
| 05/11/2006 | WO2006050236A2 Compounds and methods of use thereof |
| 05/11/2006 | WO2006049952A1 Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 05/11/2006 | WO2006048894A1 Novel crystalline forms of atorvastatin calcium and processes for preparing them. |
| 05/11/2006 | WO2006048893A2 A process for synthesis of large particle size statin compounds |
| 05/11/2006 | US20060100446 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
| 05/11/2006 | US20060100445 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
| 05/11/2006 | US20060100267 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
| 05/11/2006 | US20060100261 Furan or thiopene derivative and medicinal use thereof |
| 05/11/2006 | US20060100250 Biphenyl derivatives and their use as fungicides |
| 05/11/2006 | US20060100241 Method for enhancing mutant protein activity |
| 05/11/2006 | US20060100196 Substituted amines for the treatment of alzheimer's disease |
| 05/11/2006 | US20060100191 Kinesin spindle protein (KSP) inhibitors, e.g., 4-(2,5-Difluorophenyl)-N-[(3S,4S)-3-fluoropiperidin-4-yl]-2-hydroxymethyl)-N-methyl-2-phenyl-2,5-dihydro-1N-pyrrole-1-carboxamide, and a carrier; antiproliferative and -carcinogenic agents; side effects reduction; used with an estrogen receptor modulator |
| 05/11/2006 | US20060099222 Novel mixture and compounds from mycelia of antrodia camphorata and use thereof |
| 05/11/2006 | DE102004053192A1 2-Alkoxy-6-alkyl-phenyl substituierte spirocyclische Tetramsäure-Derivate 2-alkoxy-6-alkyl-phenyl substituted spirocyclic tetramic acid derivatives |
| 05/11/2006 | DE102004053191A1 2,6-Diethyl-4-methyl-phenyl substituierte Tetramsäure-Derivate 2,6-diethyl-4-methyl-phenyl substituted tetramic acid derivatives |
| 05/11/2006 | CA2585645A1 Ceramides and apoptosis-signaling ligand |
| 05/10/2006 | EP1655284A1 2-Phenylsulfopyrroles |
| 05/10/2006 | EP1654226A1 (2s,4s)-4-fluoro-1- 4-fluoro-beta-(4-fluorophenyl)-l-phenylalanyl -2-pyrrolidinecarbonitrile p-toluenesulfonic acid salt and anhydrous crystalline forms thereof |
| 05/10/2006 | EP1654225A2 Melanin concentrating hormone receptor antagonists |
| 05/10/2006 | EP1654224A1 Substituted benzoylureido-o-benzoylamides, method for the production thereof and use of the same |
| 05/10/2006 | EP1653945A2 Glycosidase inhibitors and methods of synthesizing same |
| 05/10/2006 | EP1560812B1 Aminocyclohexyl ether compounds and uses thereof |
| 05/10/2006 | CN1771249A Pyrazolidine-1,2-dicarboxyldiphenylamide derivatives as coagulation factor xa inhibitors for the treatment of thromboses. |
| 05/10/2006 | CN1771248A Pyrazolidine-1,2-dicarboxyldiphenylamide derivatives as coagulation factor xa inhibitors for the treatment of thromboses. |
| 05/10/2006 | CN1771237A Pyrazolidine-1,2-dicarboxyldiphenylamide derivatives as coagulation factor xa inhibitors for the treatment of thromboses. |
| 05/10/2006 | CN1771057A Releasable polymeric conjugates based on biodegradable linkers |
| 05/10/2006 | CN1771032A Polymorphs of pyrrole substituted 2-indolinone protein kinase inhibitors |
| 05/10/2006 | CN1769284A Substituted 1H-indole-2-ketone compound and its preparation method and uses |
| 05/10/2006 | CN1255402C Intermediates for the production of quinolone carboxylic acid derivatives |
| 05/10/2006 | CN1255396C Carboxylic acid derivatives having fused rings |
| 05/10/2006 | CN1255380C Pyrrolecarboxamides and pyrrolethioamides as fungicides |
| 05/09/2006 | US7041852 Perfluoroalkylanilines |
| 05/09/2006 | US7041837 Heterocyclic compounds having hypolipidemic, hypocholesteremic activities process for their preparation and pharmaceutical compositions containing them and their use in medicine |
| 05/09/2006 | US7041836 Antibiotic compounds |
| 05/09/2006 | US7041831 a [4-(5-phenyl)oxazolyl]-N-acetyl pyrrolidine or a [1-amino-2-hydroxy-2-phenylethyl]-N-acetyl pyrrolidine; enzyme inhibitors; anticarcinogenic, antitumor agents |
| 05/09/2006 | US7041698 Tripeptide analogs that inhibit the functioning of the NS3 protease encoded by Hepatitis C virus |
| 05/09/2006 | US7041690 Viricides; hepatitis virus infections |
| 05/09/2006 | US7041667 CCR5 modulators |
| 05/09/2006 | US7041314 GPE analogs and peptidominetics |
| 05/09/2006 | CA2262668C Inhibitors of cathepsin k |
| 05/04/2006 | WO2006047703A2 Synthesis of amino acid, n-carboxyanhydrides |
| 05/04/2006 | WO2006047504A1 Aromatic amides as inhibitors of c-fms kinase |
| 05/04/2006 | WO2006046690A1 Composition for oral cavity |
| 05/04/2006 | WO2006033714A3 Metal chelators and methods of their use |
| 05/04/2006 | WO2006032994A3 Muscarinic receptor antagonists |
| 05/04/2006 | WO2006012395A3 Peptidase inhibitors |
| 05/04/2006 | WO2006012227A3 Amido compounds and their use as pharmaceuticals |
| 05/04/2006 | WO2006002099A3 Factor xa inhibitors |
| 05/04/2006 | WO2005090447A3 Use of n-ethyl-2-pyrrolidone |
| 05/04/2006 | WO2004085349A3 Production of 5-methyl-1-hydrocarbyl-2-pyrrolidone by reductive amination of levulinic acid |
| 05/04/2006 | US20060094880 Producing such as 1-{2-[2-(3,4-dimethoxy-phenyl)-ethoxy]-cyclohexyl}-pyrrolidin-3-ol; antiarrhythmia agents |
| 05/04/2006 | US20060094773 3-Phenyl substituted 3-substituted-4ketolactams and ketolactones |
| 05/04/2006 | US20060094708 to treat cellular proliferative diseases, hyperplasias, solid tumor, cardiac hypertrophy, immune disorders and inflammation; modulators of one or more mitotic kinesins; N-(2-(2-dimethylamino-acetylamino)-1-{4-[8-(1-hydroxy-ethyl)-imidazo[1,2-a]pyridin-2-yl]-benzyl}-ethyl)-3-chloro-4-isopropoxy-benzamide |
| 05/03/2006 | EP1651657A2 Biphosphine ruthenium complexes with chiral diamine ligands as catalysts |
| 05/03/2006 | EP1651599A1 Tyrosine kinase inhibitors |
| 05/03/2006 | EP1651595A2 Ubiquitin ligase inhibitors |
| 05/03/2006 | EP1651209A2 Tyrosine kinase inhibitors |
| 05/03/2006 | EP1242400B1 Pyrrolidine derivatives as cyclic amp-specific phosphodiesterase inhibitors |
| 05/03/2006 | EP1227805B1 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 05/03/2006 | EP1208091B1 Benzophenones as inhibitors of reverse transcriptase |
| 05/03/2006 | EP1188755B1 Acylhydrazine derivatives, process for preparing the same and use thereof |
| 05/03/2006 | EP0793500B1 Pharmaceutical compositions comprising nitric oxide-releasing polysaccharides |
| 05/03/2006 | CN1768149A Process for producing enantiopure beta-amino acid derivatives, and enantiopure beta-amino acid derivatives |
| 05/03/2006 | CN1768035A Anti-obesity agent |
| 05/03/2006 | CN1768030A Process for producing amino acid derivatives |
| 05/03/2006 | CN1768026A 2-aryl-acetic acids, their derivatives and pharmaceutical compositions containing them |
| 05/03/2006 | CN1765900A Spiro oxazone derivative containing naphthalimide unit |
| 05/03/2006 | CN1765884A Antimycotic compound and its preparation method and uses |
| 05/02/2006 | US7038077 2-Amino-bicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivatives; nervous system, psychological, and psychiatric disorders |
| 05/02/2006 | US7038061 Analgesics; anesthetics; antiinflammatory agents; central nervous system duisorders; strokes; antiarthritic agents; inflammatory bowel disorders |
| 05/02/2006 | US7038025 Metal complexes of heterocyclic aromatic compounds |
| 05/02/2006 | US7037935 4-Pyrrolidino-phenyl-benzyl ether derivatives |
| 05/02/2006 | US7037880 Ethylene derivatives and pesticides containing said derivatives |
| 05/02/2006 | US7037412 Distilling in a distillation column a liquid, formed by adding to an odorous components-containing liquid having a N-vinyl-2-pyrrolidone purity lower than 90 wt.%, a compound with lower boiling point than N-vinyl-2-pyrrolidone |
| 05/02/2006 | CA2326804C Compounds with activity on muscarinic receptors |
| 04/27/2006 | WO2006044955A1 Phosphodiesterase 4 inhibitors |
| 04/27/2006 | WO2006044707A1 Chemical compounds |
| 04/27/2006 | WO2006044454A1 1-(hetero)aryl-3-amino-pyrollidine derivatives for use as mglur3 receptor antagonists |
| 04/27/2006 | WO2006043064A1 Piperidines and related compounds for treatment of alzheimer's disease |
| 04/27/2006 | WO2006042478A1 Small-molecule inhibitors of coronaviral main protease, their preparation and use |
| 04/27/2006 | WO2006019957A3 Heterocyclyls as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders |
| 04/27/2006 | WO2006000904A3 Preparation of pregabalin and related compounds |
| 04/27/2006 | US20060089498 3-amino-2-ethoxycarbonylpyrrole; chemical intermediate in synthesis of 3H,5H-pyrrolo[3,2-d]pyrimidin-4-one; a convergent synthesis route rather than a linear one |
| 04/27/2006 | US20060089402 Compounds from Antrodia camphorata and use thereof |
| 04/27/2006 | US20060089393 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors |
| 04/27/2006 | US20060089357 Novel compounds and compositions as cathepsin inhibitors |
| 04/27/2006 | CA2584504A1 Piperidines and related compounds for treatment of alzheimer's disease |
| 04/27/2006 | CA2584422A1 1-(hetero)aryl-3-amino-pyrollidine derivatives for use as mglur3 receptor antagonists |
| 04/27/2006 | CA2584342A1 Improved inhibitors for the soluble epoxide hydrolase |
| 04/27/2006 | CA2584328A1 Phosphodiesterase 4 inhibitors |
| 04/27/2006 | CA2583622A1 Ophthalmic compositions for treating ocular hypertension |
| 04/27/2006 | CA2582087A1 Process for preparing amorphous atorvastatin hemi-calcium by dissolving the salt in an organic solvent which is a mixture of an alcohol and a ketone and/or an ester and removing the solvent |
| 04/26/2006 | EP1648866A1 Process and intermediate compounds useful in the preparation of statins, particularly atorvastatin |
| 04/26/2006 | EP0915844B1 Process for preparing 3-pyrroline-2-carboxylic acid derivatives |